Breaking New Ground: Could Calcitonin Gene-Related Peptide Inhibitors prevent Status Epilepticus?

Neither Food nor the Use of Sprinkle Delivery Impacts the Oral Bioavailability (BA) of a Novel Extended-Release (XR) Formulation of Lacosamide

Developing Novel Therapeutic Agents Targeting NLRP3 Inflammasome Inhibition and Oxidative Stress Mitigation for Epilepsy and Neurodegenerative Disorders